WallStreetZenWallStreetZen

NASDAQ: NGNE
Neurogene Inc Stock

$31.75+0.74 (+2.39%)
Updated Jun 24, 2024
NGNE Price
$31.75
Fair Value Price
$10.29
Market Cap
$412.12M
52 Week Low
$12.20
52 Week High
$53.00
P/E
1x
P/B
2.41x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$39.03M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.14
Operating Cash Flow
-$60M
Beta
0.88
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

NGNE Overview

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NGNE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NGNE ($31.75) is overvalued by 208.55% relative to our estimate of its Fair Value price of $10.29 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NGNE ($31.75) is not significantly undervalued (208.55%) relative to our estimate of its Fair Value price of $10.29 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NGNE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
There are 30 more NGNE due diligence checks available for Premium users.

Be the first to know about important NGNE news, forecast changes, insider trades & much more!

NGNE News

Valuation

NGNE fair value

Fair Value of NGNE stock based on Discounted Cash Flow (DCF)
Price
$31.75
Fair Value
$10.29
Overvalued by
208.55%
NGNE ($31.75) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NGNE ($31.75) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

NGNE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
1x
Industry
-6.96x
Market
30.03x
NGNE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NGNE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NGNE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.41x
Industry
6.29x
NGNE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NGNE's financial health

Profit margin

Revenue
$0.0
Net Income
-$16.9M
Profit Margin
0%
NGNE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$195.4M
Liabilities
$24.6M
Debt to equity
0.14
NGNE's short-term assets ($174.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NGNE's short-term assets ($174.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NGNE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NGNE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$21.7M
Investing
$29.9M
Financing
-$6.5M
NGNE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NGNE vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NGNE$412.12M+2.39%1.00x2.41x
ACIU$411.67M+2.47%-6.19x2.59x
RNAC$410.02M+1.05%-0.41x-3.51x
EDIT$417.77M-0.59%-2.44x1.42x
PGEN$406.40M+4.55%-4.13x4.19x

Neurogene Stock FAQ

What is Neurogene's quote symbol?

(NASDAQ: NGNE) Neurogene trades on the NASDAQ under the ticker symbol NGNE. Neurogene stock quotes can also be displayed as NASDAQ: NGNE.

If you're new to stock investing, here's how to buy Neurogene stock.

What is the 52 week high and low for Neurogene (NASDAQ: NGNE)?

(NASDAQ: NGNE) Neurogene's 52-week high was $53.00, and its 52-week low was $12.20. It is currently -40.09% from its 52-week high and 160.25% from its 52-week low.

How much is Neurogene stock worth today?

(NASDAQ: NGNE) Neurogene currently has 12,980,289 outstanding shares. With Neurogene stock trading at $31.75 per share, the total value of Neurogene stock (market capitalization) is $412.12M.

Neurogene stock was originally listed at a price of $239.00 in Mar 7, 2014. If you had invested in Neurogene stock at $239.00, your return over the last 10 years would have been -86.72%, for an annualized return of -18.28% (not including any dividends or dividend reinvestments).

How much is Neurogene's stock price per share?

(NASDAQ: NGNE) Neurogene stock price per share is $31.75 today (as of Jun 24, 2024).

What is Neurogene's Market Cap?

(NASDAQ: NGNE) Neurogene's market cap is $412.12M, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neurogene's market cap is calculated by multiplying NGNE's current stock price of $31.75 by NGNE's total outstanding shares of 12,980,289.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.